Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
FSD Pharma Inc Class B
HUGECurrent price
7.47 CAD
+1.17 CAD (+18.38%)
Last closed
4.8 USD
Company
www.fsdpharma.com
ISIN
CA35954B2066
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Canadian Securities Exchange
Capitalization
66 671 USD
Yield for 12 month
-92.25 %
1Y
3Y
5Y
10Y
15Y
HUGE
FSD Pharma Inc., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. FSD Pharma Inc. is headquartered in Toronto, Canada. Address: 55 University Ave., Toronto, ON, Canada, M5J 2H7
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
2.6 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-2 552 278 USD
Last Year
-4 357 630 USD
Current Quarter
–
Last Quarter
-119 604 USD
Key Figures HUGE
1 year
3 years
5 years
10 years
EBITDA
-10 204 215 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-36.47 %
PEG Ratio
–
Return On Equity TTM
-63.89 %
Wall Street Target Price
2.6 USD
Revenue TTM
–
Book Value
17.09 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-7.4 %
Dividend Yield
–
Gross Profit TTM
-3 331 945 USD
Earnings per share
-16.25 USD
Diluted Eps TTM
-16.25 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics HUGE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History HUGE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:65
Payout Ratio
–
Last Split Date
15.08.2024
Dividend Date
16.10.2019
Stock Valuation HUGE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
98.5599
Price Sales TTM
91.8563
Enterprise Value EBITDA
-1.5744
Price Book MRQ
0.9134
Financials HUGE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators HUGE
For 52 weeks
3.5 USD
97.5 USD
50 Day MA
8.13 USD
Shares Short Prior Month
42 430
200 Day MA
36.69 USD
Short Ratio
0.11
Shares Short
176 966
Short Percent
0.44 %
BeatStart